Free Trial

Lifecore Biomedical (LFCR) Earnings Date, Estimates & Call Transcripts

Lifecore Biomedical logo
$6.87 -0.75 (-9.84%)
As of 01/6/2025 04:00 PM Eastern

Lifecore Biomedical Latest Earnings Summary

Actual EPS
(Jan. 2)
-$0.25 Beat By $0.02
Consensus EPS
(Jan. 2)
-$0.27

Lifecore Biomedical posted Q2 2025 earnings on January 2, 2025, reporting an EPS of -$0.25, which topped analysts' consensus estimates of -$0.27 by $0.02. With a trailing EPS of -$0.56 and a P/E Ratio of 85.88, Lifecore Biomedical's earnings are expected to grow next year, from ($0.99) to ($0.72) per share.

Get Lifecore Biomedical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LFCR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LFCR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lifecore Biomedical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.46-$0.46-$0.46
Q2 20251-$0.27-$0.27-$0.27
Q3 20251-$0.16-$0.16-$0.16
Q4 20251$0.01$0.01$0.01
FY 20254-$0.88-$0.88-$0.88
Q1 20261-$0.28-$0.28-$0.28
Q2 20261-$0.22-$0.22-$0.22
Q3 20261-$0.12-$0.12-$0.12
Q4 20261$0.03$0.03$0.03
FY 20264($0.59)($0.59)($0.59)

Lifecore Biomedical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
1/2/2025Q2 2025-$0.27-$0.25+$0.02-$0.25--
10/4/2024Q1 2025-$0.46-$0.53 -$0.07-$0.53$23.30M$24.71M
8/26/2024Q4 2024--$0.15 -$0.15-$0.10-$37.89M
8/9/2024Q3 2024--$0.05 -$0.05-$0.52-$35.70M
8/31/2023Q4 2023-$0.07-$0.89 -$0.82-$0.59$28.99M$31.55M
6/1/2023Q3 2023--$0.22 -$0.22$0.89-$27.60M
3/16/2023Q2 2023--$0.24 -$0.24-$0.06-$38.80M

Lifecore Biomedical Earnings - Frequently Asked Questions

Lifecore Biomedical (NASDAQ:LFCR) last announced its quarterly earning data on Thursday, January 2, 2025. Learn more on LFCR's earnings history.

Lifecore Biomedical issued an update on its FY 2025 earnings guidance on Wednesday, October, 16th. The company issued revenue guidance of $126.5 million-$130.0 million, compared to the consensus revenue estimate of $127.6 million.

In the previous quarter, Lifecore Biomedical (NASDAQ:LFCR) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.02. Learn more on analysts' earnings estimate vs. LFCR's actual earnings.

The conference call for Lifecore Biomedical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Lifecore Biomedical's latest earnings report can be read online.
Read Transcript

Lifecore Biomedical's earnings report can be found in their filing with the SEC.
View SEC filing

Lifecore Biomedical (NASDAQ:LFCR) has a recorded annual revenue of $128.44 million.

Lifecore Biomedical (NASDAQ:LFCR) has a recorded net income of $12.01 million. LFCR has generated $0.08 earnings per share over the last four quarters.

Lifecore Biomedical (NASDAQ:LFCR) has a trailing price-to-earnings ratio of 85.88.

Lifecore Biomedical's earnings are expected to grow from ($0.99) per share to ($0.72) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:LFCR) was last updated on 1/7/2025 by MarketBeat.com Staff
From Our Partners